Unresectable Leiomyosarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-05
Clinical Trial Update: Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial evaluating cabozantinib in combination with temozolomide for unresectable or metastatic leiomyosarcoma and other soft…